(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	PCP4 Gene (Entity type)	-0.0074304435
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	SSR3 Gene (Entity type)	-0.007724772
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	STMN2 Gene (Entity type)	-0.008784816
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	RNF167 Gene (Entity type)	-0.00882215
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CLEC2B Gene (Entity type)	0.01174907
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	S100P Gene (Entity type)	0.009164687
Methyltyramine Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	0.1750570088624954
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	DNAJA3 Gene (Entity type)	0.00838115
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Practolol Compound (Entity type)	0.2750596106052398
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CXCL12 Gene (Entity type)	-0.0075368704

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
PCP4
Gene (Entity type)
-0.0074304435

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
SSR3
Gene (Entity type)
-0.007724772

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
STMN2
Gene (Entity type)
-0.008784816

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
RNF167
Gene (Entity type)
-0.00882215

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CLEC2B
Gene (Entity type)
0.01174907

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
S100P
Gene (Entity type)
0.009164687

Methyltyramine
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
0.1750570088624954

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
DNAJA3
Gene (Entity type)
0.00838115

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Practolol
Compound (Entity type)
0.2750596106052398

(2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CXCL12
Gene (Entity type)
-0.0075368704

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.